This is a past event. Registration is closed. View other Asia Pacific Medical Technology Association (APACMed) events.
UPDATE:
In an effort to enhance our technical capabilities and ensure that we deliver an optimal webinar experience during this challenging period, we will be postponing the date of this webinar to:
Date: 12 May 2020, Tuesday
Time: 9am to 10am Singapore Time
All previous registrants to this event will soon receive an invite to register their interest for the webinar on the new event date of 12 May. Kindly keep an eye out for this invite.
-------------------
The MedTech industry faces a rapidly changing healthcare ecosystem across the entire Asia Pacific region. This flux has ignited interest in different methods of assessing medical technologies to inform value-based decision-making, one of which is Health Technology Assessment.
In partnership with IQVIA MedTech, APACMed has recently launched a new white paper: The Evolving Health Technology Assessment for Medical Devices and Diagnostics in the Asia Pacific Region and Key Considerations for Value Assessment Frameworks.
This authoritative report addresses the different levels of understanding around which, when and how medical technologies should be evaluated and is ideal for agencies looking to grow their knowledge base in policy and reimbursement decision making.
Join us for an exclusive webinar on Thursday, 26th March 2020, where we will hear from IQVIA Asia Pacific's Sirinthip Petcharapiruch and Boston Scientific's Virginia Priest as they share key takeaways from the paper and crucially discuss objectives and opportunities to collaboratively support value-driven medical technology assessments going forward.
Please register your interest to participate in this upcoming webinar. To download the White Paper, please click on this link: http://bit.ly/HTAWhitePaper
Login details for the webinar will be shared with registrants closer to the event date.
Thank you.
Speakers
Sirinthip
Petcharapiruch
Principal, Real World Solutions at IQVIA Asia Pacific
https://www.iqvia.com/locations/asia-pacificAs the Principal for Real World Solutions in Asia Pacific, Sirinthip heads IQVIA’s Health Economics and Outcomes Research (HEOR), Real World Evidence, HTA, and market access practice, focusing on regional Asia Pacific and South East Asia markets. She has over 12 years of experience in roles involving HEOR and generation of Real World Evidence to support product strategy and HTA submissions. Her expertise lies in developing pricing and market access strategies, aligning data to evidence requirements in the HTA market, and using Real World Evidence to support health care decision making. Prior to joining IQVIA, Sirinthip held Clinical Research, Outcomes Research and Market Access roles in pharmaceutical MNCs such as GSK and Pfizer.
Sirinthip is a pharmacist by training and she holds a Master’s degree in Healthcare Research from Queen Mary, University of London, and a Postgraduate Certificate in International HTA, Pricing and Reimbursement from the University of Sheffield. She is also a guest lecturer for the Faculty of Pharmacy at Chulalongkorn University.
Virginia
Priest
APAC Head of Health Economics and Market Access at Boston Scientific
Virginia is Head of Health Economics and Market Access for the Asia-Pacific region at Boston Scientific. She leads a team of health economists in developing strategies and evidence to support reimbursement and market access across the APAC region.
Virginia has more than 12 years of experience in health economics and market access for pharmaceuticals and medical devices, for Government payers and industry. Prior to Boston Scientific, Virginia assessed medicines for public-sector reimbursement for Australia's Pharmaceutical Benefits Advisory Committee and PHARMAC, the New Zealand Government’s Pharmaceutical Management Agency. She has worked across a broad range of therapeutic areas including oncology, infection, auto-immune diseases, ophthalmology, smoking cessation, mental health, cardiovascular and renal disease.
Sponsors and Partners
Organizer
Asia Pacific Medical Technology Association (APACMed)
Founded in 2014, the Asia Pacific Medical Technology Association (APACMed) is the only regional association to provide a unified voice for the medical technology industry in Asia Pacific.
APACMed works proactively with bilateral, regional and lcoal government bodies to shape policies, demonstrate the value of innovation and promote regulatory convergence.
IQVIA MedTech
IQVIA™ MedTech, part of IQVIA (NYSE:IQV), is dedicated to supporting the needs of the Medical Device and In Vitro Diagnostics industry, focusing on the orchestration of “concept to market” business processes to improve patient care. IQVIA MedTech Solutions are powered by the IQVIA CORE™, delivering unique and actionable insights and execution capabilities at the intersection of extensive domain expertise, transformative technology, and large-scale analytics. IQVIA is a leading global provider of information, innovative technology solutions, and contract research services.
https://www.iqvia.com/solutions/industry-segments/medical-technology